Preclinical studies of lung squamous-cell carcinoma and renal cell carcinoma reported that cancer cells with PD-L2 expression on their surface could effectively inhibit CD8+ T cell functions and play an important role as pro-tumor cells in the TME. The gene discussed is PDCD1LG2; the disease is neoplasm.